Explore
Trendline
Kahn Swick Foti Investigates Catalyst Pharmaceuticals Sale for Fairness
Kahn Swick Foti Investigates Catalyst Pharmaceuticals Sale for Fairness
Read More
Trendline
Kahn Swick Foti, LLC Investigates Catalyst Pharmaceuticals Sale for Adequacy
Kahn Swick Foti, LLC Investigates Catalyst Pharmaceuticals Sale for Adequacy
Read More
Trendline
Scotts Miracle-Gro Faces Legal Investigation Following Stock Decline
Scotts Miracle-Gro Faces Legal Investigation Following Stock Decline
Read More
Trendline
Kahn Swick Foti, LLC Initiates Investigation into Scotts Miracle-Gro Over Financial Disclosures
Kahn Swick Foti, LLC Initiates Investigation into Scotts Miracle-Gro Over Financial Disclosures
Read More
Trendline
Scotts Miracle-Gro Faces Legal Scrutiny Following Stock Decline
Scotts Miracle-Gro Faces Legal Scrutiny Following Stock Decline
Read More
Trendline
Law Firm Investigates Scotts Miracle-Gro Following Stock Decline Due to Poor Financial Results
Law Firm Investigates Scotts Miracle-Gro Following Stock Decline Due to Poor Financial Results
Read More
Trendline
Scotts Miracle-Gro Faces Legal Scrutiny After Stock Plunge
Scotts Miracle-Gro Faces Legal Scrutiny After Stock Plunge
Read More
Trendline
Southeastern Asset Management Urges Mattel to Consider Going Private Amidst Financial Challenges
Southeastern Asset Management Urges Mattel to Consider Going Private Amidst Financial Challenges
Read More
Reuters
Florida insurer Safepoint reveals 97% revenue surge in US IPO filing
May 8 (Reuters) - Safepoint on Friday filed its paperwork for a U.S. initial public offering, disclosing a 96.9% revenue jump last year as a strong run of new listings from Florida-based insurers extends into 2026.
Read More
Trendline
Angelini Pharma Acquires Catalyst Pharmaceuticals for $4.1B to Enter U.S. Rare Disease Market
Angelini Pharma Acquires Catalyst Pharmaceuticals for $4.1B to Enter U.S. Rare Disease Market
Read More
Trendline
Pomerantz Law Firm Investigates Gaia, Inc. for Potential Securities Fraud
Pomerantz Law Firm Investigates Gaia, Inc. for Potential Securities Fraud
Read More
Trendline
Innoviva Reports Strong Q1 2026 Financial Results Amid Strategic Growth
Innoviva Reports Strong Q1 2026 Financial Results Amid Strategic Growth
Read More